Details of the Drug

General Information of Drug (ID: DMFYAYL)

Drug Name

Autologous stem cell-based cancer immunotherapy

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)